Summary

The global Drug Delivery Nanoparticles Formulation market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Drug delivery nanoparticle formulations generally refer to drug delivery systems designed and prepared through nanotechnology to improve drug delivery efficiency, reduce drug dosage, reduce side effects, and achieve more precise therapeutic effects. This involves using nanomaterials as drug carriers and modulating the properties of drug delivery through specific formulations and preparation processes.
In 2025, the North America Drug Delivery Nanoparticles Formulation market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of Drug Delivery Nanoparticles Formulation include CD Bioarticles, Evonik Health Care, Sanner, Lubrizol Life Science Health (LLS Health), Kindeva Drug Delivery, Beijing TheraXyte Biotechnology, Altasciences, Stevanato Group, RiboBio, Lonza, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Drug Delivery Nanoparticles Formulation market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
CD Bioarticles
Evonik Health Care
Sanner
Lubrizol Life Science Health (LLS Health)
Kindeva Drug Delivery
Beijing TheraXyte Biotechnology
Altasciences
Stevanato Group
RiboBio
Lonza
Thermo Fisher Scientific
Catalent
Asymchem
Samsung Biologics
Segment by Type
Oral Preparation
Injectable Preparations
Skin Preparations
Others
Segment by Application
Pharmaceutical Companies
Laboratory
Others
By Region
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Markets
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term)
Chapter 2: Quantitative analysis of Drug Delivery Nanoparticles Formulation market size and growth potential at global, regional, and country levels
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus)
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities
Chapter 6: Regional revenue breakdown by company, type, application and customer
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Drug Delivery Nanoparticles Formulation value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Oral Preparation
1.2.3 Injectable Preparations
1.2.4 Skin Preparations
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Companies
1.3.3 Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Drug Delivery Nanoparticles Formulation Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Drug Delivery Nanoparticles Formulation Market Share by Revenue, by Region (2021-2026)
2.4 Global Drug Delivery Nanoparticles Formulation Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Drug Delivery Nanoparticles Formulation Market Size and Prospective (2021-2032)
2.5.2 Europe Drug Delivery Nanoparticles Formulation Market Size and Prospective (2021-2032)
2.5.3 Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size and Prospective (2021-2032)
2.5.4 Latin America Drug Delivery Nanoparticles Formulation Market Size and Prospective (2021-2032)
2.5.5 Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size and Prospective (2021-2032)

3 Breakdown Data by Type
3.1 Global Drug Delivery Nanoparticles Formulation Historical Market Size by Type (2021-2026)
3.2 Global Drug Delivery Nanoparticles Formulation Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Drug Delivery Nanoparticles Formulation

4 Breakdown Data by Application
4.1 Global Drug Delivery Nanoparticles Formulation Historical Market Size by Application (2021-2026)
4.2 Global Drug Delivery Nanoparticles Formulation Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Drug Delivery Nanoparticles Formulation Applications

5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Drug Delivery Nanoparticles Formulation Players by Revenue (2021-2026)
5.1.2 Global Drug Delivery Nanoparticles Formulation Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Drug Delivery Nanoparticles Formulation Revenue
5.4 Global Drug Delivery Nanoparticles Formulation Market Concentration Analysis
5.4.1 Global Drug Delivery Nanoparticles Formulation Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Drug Delivery Nanoparticles Formulation Revenue in 2025
5.5 Global Key Players of Drug Delivery Nanoparticles Formulation Head Offices and Areas Served
5.6 Global Key Players of Drug Delivery Nanoparticles Formulation, Product and Application
5.7 Global Key Players of Drug Delivery Nanoparticles Formulation, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Drug Delivery Nanoparticles Formulation Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Drug Delivery Nanoparticles Formulation Market Size by Type (2021-2026)
6.1.2.2 North America Drug Delivery Nanoparticles Formulation Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Drug Delivery Nanoparticles Formulation Market Size by Application (2021-2026)
6.1.3.2 North America Drug Delivery Nanoparticles Formulation Market Share by Application (2021-2026)
6.1.4 North America Drug Delivery Nanoparticles Formulation Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Drug Delivery Nanoparticles Formulation Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Drug Delivery Nanoparticles Formulation Market Size by Type (2021-2026)
6.2.2.2 Europe Drug Delivery Nanoparticles Formulation Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Drug Delivery Nanoparticles Formulation Market Size by Application (2021-2026)
6.2.3.2 Europe Drug Delivery Nanoparticles Formulation Market Share by Application (2021-2026)
6.2.4 Europe Drug Delivery Nanoparticles Formulation Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers
6.3.1 Asia-Pacific Drug Delivery Nanoparticles Formulation Revenue by Company (2021-2026)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size by Type (2021-2026)
6.3.2.2 Asia-Pacific Drug Delivery Nanoparticles Formulation Market Share by Type (2021-2026)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size by Application (2021-2026)
6.3.3.2 Asia-Pacific Drug Delivery Nanoparticles Formulation Market Share by Application (2021-2026)
6.3.4 Asia-Pacific Drug Delivery Nanoparticles Formulation Major Customers
6.3.5 Asia-Pacific Market Trends and Opportunities
6.4 Latin America Market: Players, Segments, Downstream and Major Customers
6.4.1 Latin America Drug Delivery Nanoparticles Formulation Revenue by Company (2021-2026)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Drug Delivery Nanoparticles Formulation Market Size by Type (2021-2026)
6.4.2.2 Latin America Drug Delivery Nanoparticles Formulation Market Share by Type (2021-2026)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Drug Delivery Nanoparticles Formulation Market Size by Application (2021-2026)
6.4.3.2 Latin America Drug Delivery Nanoparticles Formulation Market Share by Application (2021-2026)
6.4.4 Latin America Drug Delivery Nanoparticles Formulation Major Customers
6.4.5 Latin America Market Trends and Opportunities
6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers
6.5.1 Middle East & Africa Drug Delivery Nanoparticles Formulation Revenue by Company (2021-2026)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size by Type (2021-2026)
6.5.2.2 Middle East & Africa Drug Delivery Nanoparticles Formulation Market Share by Type (2021-2026)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size by Application (2021-2026)
6.5.3.2 Middle East & Africa Drug Delivery Nanoparticles Formulation Market Share by Application (2021-2026)
6.5.4 Middle East & Africa Drug Delivery Nanoparticles Formulation Major Customers
6.5.5 Middle East & Africa Market Trends and Opportunities

7 Key Player Profiles
7.1 CD Bioarticles
7.1.1 CD Bioarticles Company Details
7.1.2 CD Bioarticles Business Overview
7.1.3 CD Bioarticles Drug Delivery Nanoparticles Formulation Introduction
7.1.4 CD Bioarticles Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026)
7.1.5 CD Bioarticles Recent Development
7.2 Evonik Health Care
7.2.1 Evonik Health Care Company Details
7.2.2 Evonik Health Care Business Overview
7.2.3 Evonik Health Care Drug Delivery Nanoparticles Formulation Introduction
7.2.4 Evonik Health Care Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026)
7.2.5 Evonik Health Care Recent Development
7.3 Sanner
7.3.1 Sanner Company Details
7.3.2 Sanner Business Overview
7.3.3 Sanner Drug Delivery Nanoparticles Formulation Introduction
7.3.4 Sanner Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026)
7.3.5 Sanner Recent Development
7.4 Lubrizol Life Science Health (LLS Health)
7.4.1 Lubrizol Life Science Health (LLS Health) Company Details
7.4.2 Lubrizol Life Science Health (LLS Health) Business Overview
7.4.3 Lubrizol Life Science Health (LLS Health) Drug Delivery Nanoparticles Formulation Introduction
7.4.4 Lubrizol Life Science Health (LLS Health) Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026)
7.4.5 Lubrizol Life Science Health (LLS Health) Recent Development
7.5 Kindeva Drug Delivery
7.5.1 Kindeva Drug Delivery Company Details
7.5.2 Kindeva Drug Delivery Business Overview
7.5.3 Kindeva Drug Delivery Drug Delivery Nanoparticles Formulation Introduction
7.5.4 Kindeva Drug Delivery Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026)
7.5.5 Kindeva Drug Delivery Recent Development
7.6 Beijing TheraXyte Biotechnology
7.6.1 Beijing TheraXyte Biotechnology Company Details
7.6.2 Beijing TheraXyte Biotechnology Business Overview
7.6.3 Beijing TheraXyte Biotechnology Drug Delivery Nanoparticles Formulation Introduction
7.6.4 Beijing TheraXyte Biotechnology Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026)
7.6.5 Beijing TheraXyte Biotechnology Recent Development
7.7 Altasciences
7.7.1 Altasciences Company Details
7.7.2 Altasciences Business Overview
7.7.3 Altasciences Drug Delivery Nanoparticles Formulation Introduction
7.7.4 Altasciences Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026)
7.7.5 Altasciences Recent Development
7.8 Stevanato Group
7.8.1 Stevanato Group Company Details
7.8.2 Stevanato Group Business Overview
7.8.3 Stevanato Group Drug Delivery Nanoparticles Formulation Introduction
7.8.4 Stevanato Group Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026)
7.8.5 Stevanato Group Recent Development
7.9 RiboBio
7.9.1 RiboBio Company Details
7.9.2 RiboBio Business Overview
7.9.3 RiboBio Drug Delivery Nanoparticles Formulation Introduction
7.9.4 RiboBio Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026)
7.9.5 RiboBio Recent Development
7.10 Lonza
7.10.1 Lonza Company Details
7.10.2 Lonza Business Overview
7.10.3 Lonza Drug Delivery Nanoparticles Formulation Introduction
7.10.4 Lonza Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026)
7.10.5 Lonza Recent Development
7.11 Thermo Fisher Scientific
7.11.1 Thermo Fisher Scientific Company Details
7.11.2 Thermo Fisher Scientific Business Overview
7.11.3 Thermo Fisher Scientific Drug Delivery Nanoparticles Formulation Introduction
7.11.4 Thermo Fisher Scientific Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026)
7.11.5 Thermo Fisher Scientific Recent Development
7.12 Catalent
7.12.1 Catalent Company Details
7.12.2 Catalent Business Overview
7.12.3 Catalent Drug Delivery Nanoparticles Formulation Introduction
7.12.4 Catalent Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026)
7.12.5 Catalent Recent Development
7.13 Asymchem
7.13.1 Asymchem Company Details
7.13.2 Asymchem Business Overview
7.13.3 Asymchem Drug Delivery Nanoparticles Formulation Introduction
7.13.4 Asymchem Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026)
7.13.5 Asymchem Recent Development
7.14 Samsung Biologics
7.14.1 Samsung Biologics Company Details
7.14.2 Samsung Biologics Business Overview
7.14.3 Samsung Biologics Drug Delivery Nanoparticles Formulation Introduction
7.14.4 Samsung Biologics Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026)
7.14.5 Samsung Biologics Recent Development

8 Drug Delivery Nanoparticles Formulation Market Dynamics
8.1 Drug Delivery Nanoparticles Formulation Industry Trends
8.2 Drug Delivery Nanoparticles Formulation Market Drivers
8.3 Drug Delivery Nanoparticles Formulation Market Challenges
8.4 Drug Delivery Nanoparticles Formulation Market Restraints

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Drug Delivery Nanoparticles Formulation Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Global Drug Delivery Nanoparticles Formulation Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 3. Global Market Drug Delivery Nanoparticles Formulation Market Size (US$ Million) by Region:2021 vs 2025 vs 2032
Table 4. Global Drug Delivery Nanoparticles Formulation Revenue (US$ Million) Market Share by Region (2021-2026)
Table 5. Global Drug Delivery Nanoparticles Formulation Revenue Share by Region (2021-2026)
Table 6. Global Drug Delivery Nanoparticles Formulation Revenue (US$ Million) Forecast by Region (2027-2032)
Table 7. Global Drug Delivery Nanoparticles Formulation Revenue Share Forecast by Region (2027-2032)
Table 8. Global Drug Delivery Nanoparticles Formulation Market Size by Type (2021-2026) & (US$ Million)
Table 9. Global Drug Delivery Nanoparticles Formulation Market Share by Revenue, by Type (2021-2026)
Table 10. Global Drug Delivery Nanoparticles Formulation Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 11. Global Drug Delivery Nanoparticles Formulation Market Share by Revenue, by Type (2027-2032)
Table 12. Representative Players of Each Type
Table 13. Global Drug Delivery Nanoparticles Formulation Market Size by Application (2021-2026) & (US$ Million)
Table 14. Global Drug Delivery Nanoparticles Formulation Market Share by Revenue, by Application (2021-2026)
Table 15. Global Drug Delivery Nanoparticles Formulation Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 16. Global Drug Delivery Nanoparticles Formulation Market Share by Revenue, by Application (2027-2032)
Table 17. New Sources of Growth in Drug Delivery Nanoparticles Formulation Applications
Table 18. Global Drug Delivery Nanoparticles Formulation Revenue by Players (2021-2026) & (US$ Million)
Table 19. Global Drug Delivery Nanoparticles Formulation Market Share by Players (2021-2026)
Table 20. Global Top Drug Delivery Nanoparticles Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery Nanoparticles Formulation as of 2025)
Table 21. Ranking of Global Top Drug Delivery Nanoparticles Formulation Companies by Revenue (US$ Million) in 2025
Table 22. Global 5 Largest Players Market Share by Drug Delivery Nanoparticles Formulation Revenue (CR5 and HHI) & (2021-2026)
Table 23. Global Key Players of Drug Delivery Nanoparticles Formulation, Headquarters and Area Served
Table 24. Global Key Players of Drug Delivery Nanoparticles Formulation, Product and Application
Table 25. Global Key Players of Drug Delivery Nanoparticles Formulation, Date of Entry into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Drug Delivery Nanoparticles Formulation Revenue by Company (2021-2026) & (US$ Million)
Table 28. North America Drug Delivery Nanoparticles Formulation Market Share by Revenue, by Company (2021-2026)
Table 29. North America Drug Delivery Nanoparticles Formulation Market Size by Type (2021-2026) & (US$ Million)
Table 30. North America Drug Delivery Nanoparticles Formulation Market Size by Application (2021-2026) & (US$ Million)
Table 31. Europe Drug Delivery Nanoparticles Formulation Revenue by Company (2021-2026) & (US$ Million)
Table 32. Europe Drug Delivery Nanoparticles Formulation Market Share by Revenue, by Company (2021-2026)
Table 33. Europe Drug Delivery Nanoparticles Formulation Market Size by Type (2021-2026) & (US$ Million)
Table 34. Europe Drug Delivery Nanoparticles Formulation Market Size by Application (2021-2026) & (US$ Million)
Table 35. Asia-Pacific Drug Delivery Nanoparticles Formulation Revenue by Company (2021-2026) & (US$ Million)
Table 36. Asia-Pacific Drug Delivery Nanoparticles Formulation Market Share by Revenue, by Company (2021-2026)
Table 37. Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size by Type (2021-2026) & (US$ Million)
Table 38. Asia-Pacific Drug Delivery Nanoparticles Formulation Market Size by Application (2021-2026) & (US$ Million)
Table 39. Latin America Drug Delivery Nanoparticles Formulation Revenue by Company (2021-2026) & (US$ Million)
Table 40. Latin America Drug Delivery Nanoparticles Formulation Market Share by Revenue, by Company (2021-2026)
Table 41. Latin America Drug Delivery Nanoparticles Formulation Market Size by Type (2021-2026) & (US$ Million)
Table 42. Latin America Drug Delivery Nanoparticles Formulation Market Size by Application (2021-2026) & (US$ Million)
Table 43. Middle East & Africa Drug Delivery Nanoparticles Formulation Revenue by Company (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Drug Delivery Nanoparticles Formulation Market Share by Revenue, by Company (2021-2026)
Table 45. Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size by Type (2021-2026) & (US$ Million)
Table 46. Middle East & Africa Drug Delivery Nanoparticles Formulation Market Size by Application (2021-2026) & (US$ Million)
Table 47. CD Bioarticles Company Details
Table 48. CD Bioarticles Business Overview
Table 49. CD Bioarticles Drug Delivery Nanoparticles Formulation Product
Table 50. CD Bioarticles Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026) & (US$ Million)
Table 51. CD Bioarticles Recent Development
Table 52. Evonik Health Care Company Details
Table 53. Evonik Health Care Business Overview
Table 54. Evonik Health Care Drug Delivery Nanoparticles Formulation Product
Table 55. Evonik Health Care Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026) & (US$ Million)
Table 56. Evonik Health Care Recent Development
Table 57. Sanner Company Details
Table 58. Sanner Business Overview
Table 59. Sanner Drug Delivery Nanoparticles Formulation Product
Table 60. Sanner Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026) & (US$ Million)
Table 61. Sanner Recent Development
Table 62. Lubrizol Life Science Health (LLS Health) Company Details
Table 63. Lubrizol Life Science Health (LLS Health) Business Overview
Table 64. Lubrizol Life Science Health (LLS Health) Drug Delivery Nanoparticles Formulation Product
Table 65. Lubrizol Life Science Health (LLS Health) Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026) & (US$ Million)
Table 66. Lubrizol Life Science Health (LLS Health) Recent Development
Table 67. Kindeva Drug Delivery Company Details
Table 68. Kindeva Drug Delivery Business Overview
Table 69. Kindeva Drug Delivery Drug Delivery Nanoparticles Formulation Product
Table 70. Kindeva Drug Delivery Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026) & (US$ Million)
Table 71. Kindeva Drug Delivery Recent Development
Table 72. Beijing TheraXyte Biotechnology Company Details
Table 73. Beijing TheraXyte Biotechnology Business Overview
Table 74. Beijing TheraXyte Biotechnology Drug Delivery Nanoparticles Formulation Product
Table 75. Beijing TheraXyte Biotechnology Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026) & (US$ Million)
Table 76. Beijing TheraXyte Biotechnology Recent Development
Table 77. Altasciences Company Details
Table 78. Altasciences Business Overview
Table 79. Altasciences Drug Delivery Nanoparticles Formulation Product
Table 80. Altasciences Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026) & (US$ Million)
Table 81. Altasciences Recent Development
Table 82. Stevanato Group Company Details
Table 83. Stevanato Group Business Overview
Table 84. Stevanato Group Drug Delivery Nanoparticles Formulation Product
Table 85. Stevanato Group Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026) & (US$ Million)
Table 86. Stevanato Group Recent Development
Table 87. RiboBio Company Details
Table 88. RiboBio Business Overview
Table 89. RiboBio Drug Delivery Nanoparticles Formulation Product
Table 90. RiboBio Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026) & (US$ Million)
Table 91. RiboBio Recent Development
Table 92. Lonza Company Details
Table 93. Lonza Business Overview
Table 94. Lonza Drug Delivery Nanoparticles Formulation Product
Table 95. Lonza Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026) & (US$ Million)
Table 96. Lonza Recent Development
Table 97. Thermo Fisher Scientific Company Details
Table 98. Thermo Fisher Scientific Business Overview
Table 99. Thermo Fisher Scientific Drug Delivery Nanoparticles Formulation Product
Table 100. Thermo Fisher Scientific Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026) & (US$ Million)
Table 101. Thermo Fisher Scientific Recent Development
Table 102. Catalent Company Details
Table 103. Catalent Business Overview
Table 104. Catalent Drug Delivery Nanoparticles Formulation Product
Table 105. Catalent Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026) & (US$ Million)
Table 106. Catalent Recent Development
Table 107. Asymchem Company Details
Table 108. Asymchem Business Overview
Table 109. Asymchem Drug Delivery Nanoparticles Formulation Product
Table 110. Asymchem Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026) & (US$ Million)
Table 111. Asymchem Recent Development
Table 112. Samsung Biologics Company Details
Table 113. Samsung Biologics Business Overview
Table 114. Samsung Biologics Drug Delivery Nanoparticles Formulation Product
Table 115. Samsung Biologics Revenue in Drug Delivery Nanoparticles Formulation Business (2021-2026) & (US$ Million)
Table 116. Samsung Biologics Recent Development
Table 117. Drug Delivery Nanoparticles Formulation Market Trends
Table 118. Drug Delivery Nanoparticles Formulation Market Drivers
Table 119. Drug Delivery Nanoparticles Formulation Market Challenges
Table 120. Drug Delivery Nanoparticles Formulation Market Restraints
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources

List of Figures
Figure 1. Drug Delivery Nanoparticles Formulation Product Picture
Figure 2. Global Drug Delivery Nanoparticles Formulation Market Share by Type: 2025 vs 2032
Figure 3. Oral Preparation Features
Figure 4. Injectable Preparations Features
Figure 5. Skin Preparations Features
Figure 6. Others Features
Figure 7. Global Drug Delivery Nanoparticles Formulation Market Share by Application: 2025 vs 2032
Figure 8. Pharmaceutical Companies
Figure 9. Laboratory
Figure 10. Others
Figure 11. Drug Delivery Nanoparticles Formulation Report Years Considered
Figure 12. Global Drug Delivery Nanoparticles Formulation Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 13. Global Drug Delivery Nanoparticles Formulation Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Drug Delivery Nanoparticles Formulation Market Share by Revenue, by Region: 2021 vs 2025
Figure 15. North America Drug Delivery Nanoparticles Formulation Revenue (US$ Million) Growth Rate (2021-2032)
Figure 16. Europe Drug Delivery Nanoparticles Formulation Revenue (US$ Million) Growth Rate (2021-2032)
Figure 17. Asia-Pacific Drug Delivery Nanoparticles Formulation Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. Latin America Drug Delivery Nanoparticles Formulation Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. Middle East & Africa Drug Delivery Nanoparticles Formulation Revenue (US$ Million) Growth Rate (2021-2032)
Figure 20. Global Drug Delivery Nanoparticles Formulation Market Share by Players in 2025
Figure 21. Global Top Drug Delivery Nanoparticles Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery Nanoparticles Formulation as of 2025)
Figure 22. The Top 10 and 5 Players Market Share by Drug Delivery Nanoparticles Formulation Revenue in 2025
Figure 23. North America Drug Delivery Nanoparticles Formulation Market Share by Type (2021-2026)
Figure 24. North America Drug Delivery Nanoparticles Formulation Market Share by Application (2021-2026)
Figure 25. Europe Drug Delivery Nanoparticles Formulation Market Share by Type (2021-2026)
Figure 26. Europe Drug Delivery Nanoparticles Formulation Market Share by Application (2021-2026)
Figure 27. Asia-Pacific Drug Delivery Nanoparticles Formulation Market Share by Type (2021-2026)
Figure 28. Asia-Pacific Drug Delivery Nanoparticles Formulation Market Share by Application (2021-2026)
Figure 29. Latin America Drug Delivery Nanoparticles Formulation Market Share by Type (2021-2026)
Figure 30. Latin America Drug Delivery Nanoparticles Formulation Market Share by Application (2021-2026)
Figure 31. Middle East & Africa Drug Delivery Nanoparticles Formulation Market Share by Type (2021-2026)
Figure 32. Middle East & Africa Drug Delivery Nanoparticles Formulation Market Share by Application (2021-2026)
Figure 33. CD Bioarticles Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2021-2026)
Figure 34. Evonik Health Care Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2021-2026)
Figure 35. Sanner Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2021-2026)
Figure 36. Lubrizol Life Science Health (LLS Health) Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2021-2026)
Figure 37. Kindeva Drug Delivery Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2021-2026)
Figure 38. Beijing TheraXyte Biotechnology Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2021-2026)
Figure 39. Altasciences Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2021-2026)
Figure 40. Stevanato Group Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2021-2026)
Figure 41. RiboBio Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2021-2026)
Figure 42. Lonza Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2021-2026)
Figure 43. Thermo Fisher Scientific Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2021-2026)
Figure 44. Catalent Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2021-2026)
Figure 45. Asymchem Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2021-2026)
Figure 46. Samsung Biologics Revenue Growth Rate in Drug Delivery Nanoparticles Formulation Business (2021-2026)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed